Apotex Inc. is the largest Canadian-owned pharmaceutical company. It produces more than 300 generic pharmaceuticals. The company’s pharmaceuticals are exported to over 115 countries around the globe.
Although the company’s own business is developing and manufacturing generic pharmaceuticals, the success of Apotex has enabled it to diversify into a number of other health-related areas.
ApoPharma is the Innovative Drug Division of Apotex Inc. Research and development of Ferriprox, an iron chelator and a new iron chelators in a variety of indications remain key focuses for ApoPharma. Equally important is the progression towards market of a novel treatment for difficult to heal woulds, such as diabetic foot ulcers.